0001209191-21-018569.txt : 20210308 0001209191-21-018569.hdr.sgml : 20210308 20210308163806 ACCESSION NUMBER: 0001209191-21-018569 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210304 FILED AS OF DATE: 20210308 DATE AS OF CHANGE: 20210308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kosacz Barbara CENTRAL INDEX KEY: 0001763316 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39503 FILM NUMBER: 21722452 MAIL ADDRESS: STREET 1: 3175 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athira Pharma, Inc. CENTRAL INDEX KEY: 0001620463 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 453368487 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104 CITY: BOTHELL STATE: WA ZIP: 98011 BUSINESS PHONE: (206) 221-8112 MAIL ADDRESS: STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104 CITY: BOTHELL STATE: WA ZIP: 98011 FORMER COMPANY: FORMER CONFORMED NAME: M3 Biotechnology, Inc. DATE OF NAME CHANGE: 20140924 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-04 0 0001620463 Athira Pharma, Inc. ATHA 0001763316 Kosacz Barbara C/O ATHIRA PHARMA, INC. 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 1 0 0 0 Stock Option (Right to Buy) 19.29 2021-03-04 4 A 0 27742 0.00 A 2031-03-03 Common Stock 27742 27742 D One thirty-sixth of the shares subject to the option will vest on April 4, 2021 and one thirty-sixth of the shares subject to the option will vest each month thereafter. Glenna Mileson, Attorney in fact for Barbara Kosacz 2021-03-08